Table 2 The probability of a vaccine being selected and rank-ordering of vaccines among groups of respondents
From: What criteria do decision makers in Thailand use to set priorities for vaccine introduction?
Ranking | Policy maker (n = 11) | Healthcare professional (n = 26) | Healthcare administrator (n = 33) | All respondents (n = 70) | ||||
|---|---|---|---|---|---|---|---|---|
Vaccine | Probability of selection (%) (95Â % CI) | Vaccine | Probability of selection (%) (95Â % CI) | Vaccine | Probability of selection (%) (95Â % CI) | Vaccine | Probability of selection (%) (95Â % CI) | |
1 | HepB | 91.64 (71.40–97.97) | HepB | 95.35 (88.70–98.17) | HepB | 96.05 (88.62–98.70) | HepB | 96.67 (93.24–98.39) |
2 | PCV-13 | 87.24 (60.88–96.78) | PCV-13 | 93.19 (83.99–97.28) | PCV-13 | 94.70 (85.13–98.24) | PCV-13 | 95.09 (90.20–97.60) |
3 | Hib | 78.75 (45.75–94.21) | Hib | 81.78 (63.22–92.14) | Hib | 91.75 (78.08–97.20) | Hib | 90.87 (82.56–95.44) |
4 | JE | 60.29 (25.68–86.96) | JE | 73.16 (51.08–87.68) | JE | 59.42 (31.92–82.06) | JE | 67.80 (50.03–81.59) |
5 | Rotavirus | 33.88 (10.44–69.24) | Rotavirus | 27.35 (12.60–49.56) | Rotavirus | 52.89 (26.45–77.81) | Rotavirus | 33.43 (19.27–51.37) |